New nanotechnology research study turns brain tumors blue

March 18, 2013, Children's Healthcare of Atlanta

(Medical Xpress)—In an article published this week in the journal Drug Delivery and Translational Research, researchers from Children's Healthcare of Atlanta and the Georgia Institute of Technology have reported the development of a technique that assists in identifying tumors from normal brain tissue during surgery by staining tumor cells blue. This key finding, developed by a team led by Dr. Barun Brahma, M.D., Children's neurosurgeon and biomedical engineer, and Prof. Ravi Bellamkonda, the Carol Ann and David D. Flanagan Chair in Biomedical Engineering at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, could be a critical technique used in hospitals lacking sophisticated equipment like an MRI, which guides in tumor removal, in preserving the maximum amount of normal tissue and brain function during surgery.

The project began when Children's Dr. Brahma approached the Georgia Tech-based laboratory of Prof. Bellamkonda and wondered if there was a way to manually distinguish a tumor from normal tissue during surgery without using complex equipment that might be unavailable to some health facilities. Prof. Bellamkonda's lab developed a nanocarrier made out of fat that carried a clinically approved dye called Evans Blue. The team demonstrated that these nanocarriers leak out of blood vessels in the tumor margin and stain brain tumors blue. Using injected into a rat brain, the team proved that injecting the blue-stained nanocarrers into the blood stream caused the nanocarriers to find their way to the brain tumor and selectively dye it blue while excluding normal .

The finding is significant for hospitals worldwide that lack machines to help guide , such as an intraoperative . This new technique has the potential to help neurosurgeons remove brain tumors in children more accurately all over the world.

Dr. Brahma, Prof. Bellamkonda and other collaborators are developing a range of nanotechnologies designed to treat and traumatic brain and spinal cord injuries. Other authors on the report include researchers from the Bellamkonda lab and Biomedical Engineering Assistant Professor Phil Santangelo, an optical imaging expert at Georgia Tech. This collaboration embodies the power and potential of the rapidly growing partnership between Children's and Georgia Tech.

This research effort is in collaboration with the Children's Neurosciences Center. This effort is part of the Emory+Children's Pediatric Research Center led by Children's Healthcare of Atlanta and Emory University, including partnerships with the Georgia Institute of Technology and Morehouse School of Medicine.

This research was funded by Ian's Friends Foundation in Atlanta and the Georgia Cancer Coalition.

Explore further: Imipramine blue: Novel compound halts tumor spread, improves brain cancer treatment in animal studies

More information: link.springer.com/article/10.1 … %2Fs13346-013-0139-x

Related Stories

Imipramine blue: Novel compound halts tumor spread, improves brain cancer treatment in animal studies

March 28, 2012
Treating invasive brain tumors with a combination of chemotherapy and radiation has improved clinical outcomes, but few patients survive longer than two years after diagnosis. The effectiveness of the treatment is limited ...

University Hospitals Seidman Cancer Center tests novel drug that makes brain tumors glow hot pink

December 1, 2011
Just 24 hours after Lisa Rek sang at her niece's wedding, her husband Brad was driving her to a local hospital.

New probe provides vital assist in brain cancer surgery

July 24, 2012
A new probe developed collaboratively at Norris Cotton Cancer Center and Dartmouth College's Thayer School of Engineering uses an innovative fluorescence-reading technology to help brain surgeons distinguish cancerous tissue ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.